Carbon monoxide: An emerging therapy for acute kidney injury.
Med Res Rev
; 40(4): 1147-1177, 2020 07.
Article
in En
| MEDLINE
| ID: mdl-31820474
ABSTRACT
Treating acute kidney injury (AKI) represents an important unmet medical need both in terms of the seriousness of this medical problem and the number of patients. There is also a large untapped market opportunity in treating AKI. Over the years, there has been much effort in search of therapeutics with minimal success. However, over the same time period, new understanding of the underlying pathobiology and molecular mechanisms of kidney injury have undoubtedly helped the search for new therapeutics. Along this line, carbon monoxide (CO) has emerged as a promising therapeutic agent because of its demonstrated cytoprotective, and immunomodulatory effects. CO has also been shown to sensitize cancer, but not normal cells, to chemotherapy. This is particularly important in treating cisplatin-induced AKI, a common clinical problem that develops in patients receiving cisplatin therapies for a number of different solid organ malignancies. This review will examine and make the case that CO be developed into a therapeutic agent against AKI.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carbon Monoxide
/
Acute Kidney Injury
Type of study:
Etiology_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Med Res Rev
Year:
2020
Document type:
Article
Affiliation country: